Amphastar Pharmaceuticals Inc (AMPH)
39.32
+0.69
(+1.79%)
USD |
NASDAQ |
Apr 19, 12:45
Amphastar Pharmaceuticals Shareholders Equity (Quarterly): 639.42M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 639.42M |
| September 30, 2023 | 595.14M |
| June 30, 2023 | 589.24M |
| March 31, 2023 | 548.58M |
| December 31, 2022 | 528.66M |
| September 30, 2022 | 505.16M |
| June 30, 2022 | 499.31M |
| March 31, 2022 | 479.52M |
| December 31, 2021 | 445.52M |
| September 30, 2021 | 430.18M |
| June 30, 2021 | 421.99M |
| March 31, 2021 | 405.56M |
| December 31, 2020 | 402.31M |
| September 30, 2020 | 405.23M |
| June 30, 2020 | 397.68M |
| March 31, 2020 | 377.51M |
| December 31, 2019 | 381.37M |
| September 30, 2019 | 389.40M |
| June 30, 2019 | 387.84M |
| March 31, 2019 | 334.99M |
| December 31, 2018 | 332.44M |
| Date | Value |
|---|---|
| September 30, 2018 | 319.42M |
| June 30, 2018 | 320.53M |
| March 31, 2018 | 327.10M |
| December 31, 2017 | 333.74M |
| September 30, 2017 | 330.66M |
| June 30, 2017 | 333.31M |
| March 31, 2017 | 325.56M |
| December 31, 2016 | 329.26M |
| September 30, 2016 | 328.45M |
| June 30, 2016 | 307.46M |
| March 31, 2016 | 296.58M |
| December 31, 2015 | 295.51M |
| September 30, 2015 | 283.79M |
| June 30, 2015 | 285.26M |
| March 31, 2015 | 279.28M |
| December 31, 2014 | 281.86M |
| September 30, 2014 | 283.12M |
| June 30, 2014 | 287.74M |
| March 31, 2014 | 251.54M |
| December 31, 2013 | 251.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
377.51M
Minimum
Mar 2020
639.42M
Maximum
Dec 2023
464.72M
Average
430.18M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 10.77B |
| Dentsply Sirona Inc | 3.293B |
| Pacira BioSciences Inc | 870.13M |
| Organon & Co | -70.00M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.513B |
| Total Liabilities (Quarterly) | 873.49M |
| Debt to Equity Ratio | 0.9227 |
| Current Ratio | 2.172 |
| Net Debt Paydown Yield | -3.46% |